- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Glutamate Receptor Ionotropic NMDA 2B market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Glutamate Receptor Ionotropic NMDA 2B market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Acute Ischemic Stroke accounting for % of the Glutamate Receptor Ionotropic NMDA 2B global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While JNJ-0808 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Glutamate Receptor Ionotropic NMDA 2B include BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, and Luc Therapeutics, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Glutamate Receptor Ionotropic NMDA 2B market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others
Market segment by Application can be divided into
Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others
The key market players for global Glutamate Receptor Ionotropic NMDA 2B market are listed below:
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glutamate Receptor Ionotropic NMDA 2B product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glutamate Receptor Ionotropic NMDA 2B, with price, sales, revenue and global market share of Glutamate Receptor Ionotropic NMDA 2B from 2019 to 2022.
Chapter 3, the Glutamate Receptor Ionotropic NMDA 2B competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glutamate Receptor Ionotropic NMDA 2B breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Glutamate Receptor Ionotropic NMDA 2B market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Glutamate Receptor Ionotropic NMDA 2B.
Chapter 13, 14, and 15, to describe Glutamate Receptor Ionotropic NMDA 2B sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Glutamate Receptor Ionotropic NMDA 2B Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 JNJ-0808
1.2.3 Neu-2000
1.2.4 NP-10679
1.2.5 NP-11948
1.2.6 Radiprodil
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Acute Ischemic Stroke
1.3.3 Autism
1.3.4 Brain Ischemia
1.3.5 Burns
1.3.6 Others
1.4 Global Glutamate Receptor Ionotropic NMDA 2B Market Size & Forecast
1.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume (2017-2028)
1.4.3 Global Glutamate Receptor Ionotropic NMDA 2B Price (2017-2028)
1.5 Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity Analysis
1.5.1 Global Glutamate Receptor Ionotropic NMDA 2B Total Production Capacity (2017-2028)
1.5.2 Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glutamate Receptor Ionotropic NMDA 2B Market Drivers
1.6.2 Glutamate Receptor Ionotropic NMDA 2B Market Restraints
1.6.3 Glutamate Receptor Ionotropic NMDA 2B Trends Analysis
2 Manufacturers Profiles
2.1 BioCrea GmbH
2.1.1 BioCrea GmbH Details
2.1.2 BioCrea GmbH Major Business
2.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product and Services
2.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product and Services
2.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cerecor Inc.
2.3.1 Cerecor Inc. Details
2.3.2 Cerecor Inc. Major Business
2.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product and Services
2.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product and Services
2.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Luc Therapeutics, Inc.
2.5.1 Luc Therapeutics, Inc. Details
2.5.2 Luc Therapeutics, Inc. Major Business
2.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product and Services
2.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 NeurOp, Inc
2.6.1 NeurOp, Inc Details
2.6.2 NeurOp, Inc Major Business
2.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product and Services
2.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business
2.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product and Services
2.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 UCB S.A.
2.8.1 UCB S.A. Details
2.8.2 UCB S.A. Major Business
2.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product and Services
2.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Manufacturer
3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Glutamate Receptor Ionotropic NMDA 2B
3.4 Market Concentration Rate
3.4.1 Top 3 Glutamate Receptor Ionotropic NMDA 2B Manufacturer Market Share in 2021
3.4.2 Top 6 Glutamate Receptor Ionotropic NMDA 2B Manufacturer Market Share in 2021
3.5 Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Glutamate Receptor Ionotropic NMDA 2B Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region
4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2017-2028)
4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2017-2028)
4.2 North America Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028)
4.3 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028)
4.4 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028)
4.5 South America Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028)
4.6 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Type (2017-2028)
5.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2017-2028)
5.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Application (2017-2028)
6.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2017-2028)
6.3 Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2028)
7.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2028)
7.3 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
7.3.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028)
7.3.2 North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2028)
8.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2028)
8.3 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
8.3.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028)
8.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2028)
9.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2028)
9.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size by Region
9.3.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2028)
10.2 South America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2028)
10.3 South America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
10.3.1 South America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028)
10.3.2 South America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2028)
11.2 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2028)
11.3 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
11.3.1 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Glutamate Receptor Ionotropic NMDA 2B and Key Manufacturers
12.2 Manufacturing Costs Percentage of Glutamate Receptor Ionotropic NMDA 2B
12.3 Glutamate Receptor Ionotropic NMDA 2B Production Process
12.4 Glutamate Receptor Ionotropic NMDA 2B Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Glutamate Receptor Ionotropic NMDA 2B Typical Distributors
13.3 Glutamate Receptor Ionotropic NMDA 2B Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. BioCrea GmbH Basic Information, Manufacturing Base and Competitors
Table 4. BioCrea GmbH Major Business
Table 5. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 6. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Company Major Business
Table 9. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 10. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Cerecor Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Cerecor Inc. Major Business
Table 13. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 14. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 18. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Luc Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Luc Therapeutics, Inc. Major Business
Table 21. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 22. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. NeurOp, Inc Basic Information, Manufacturing Base and Competitors
Table 24. NeurOp, Inc Major Business
Table 25. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 26. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 28. Novartis AG Major Business
Table 29. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 30. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. UCB S.A. Basic Information, Manufacturing Base and Competitors
Table 32. UCB S.A. Major Business
Table 33. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 34. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 36. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Glutamate Receptor Ionotropic NMDA 2B, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and Glutamate Receptor Ionotropic NMDA 2B Production Site of Key Manufacturer
Table 40. Glutamate Receptor Ionotropic NMDA 2B New Entrant and Capacity Expansion Plans
Table 41. Glutamate Receptor Ionotropic NMDA 2B Mergers & Acquisitions in the Past Five Years
Table 42. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2017-2022) & (K Pcs)
Table 43. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2023-2028) & (K Pcs)
Table 44. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 47. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2023-2028) & (K Pcs)
Table 48. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2017-2022) & (USD/Pcs)
Table 51. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2023-2028) & (USD/Pcs)
Table 52. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 53. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2023-2028) & (K Pcs)
Table 54. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2017-2022) & (USD/Pcs)
Table 57. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2023-2028) & (USD/Pcs)
Table 58. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022) & (K Pcs)
Table 59. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2023-2028) & (K Pcs)
Table 60. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 63. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2023-2028) & (K Pcs)
Table 64. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 65. North America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022) & (K Pcs)
Table 67. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2023-2028) & (K Pcs)
Table 68. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 71. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2023-2028) & (K Pcs)
Table 72. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 73. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2023-2028) & (K Pcs)
Table 74. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2017-2022) & (K Pcs)
Table 75. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2023-2028) & (K Pcs)
Table 76. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 79. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2023-2028) & (K Pcs)
Table 80. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 81. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2023-2028) & (K Pcs)
Table 82. South America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022) & (K Pcs)
Table 83. South America Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2023-2028) & (K Pcs)
Table 84. South America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 87. South America Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2023-2028) & (K Pcs)
Table 88. South America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 89. South America Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2023-2028) & (K Pcs)
Table 90. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2017-2022) & (K Pcs)
Table 91. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2023-2028) & (K Pcs)
Table 92. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 95. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2023-2028) & (K Pcs)
Table 96. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 97. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2023-2028) & (K Pcs)
Table 98. Glutamate Receptor Ionotropic NMDA 2B Raw Material
Table 99. Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Glutamate Receptor Ionotropic NMDA 2B Typical Distributors
Table 103. Glutamate Receptor Ionotropic NMDA 2B Typical Customers
List of Figures
Figure 1. Glutamate Receptor Ionotropic NMDA 2B Picture
Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type in 2021
Figure 3. JNJ-0808
Figure 4. Neu-2000
Figure 5. NP-10679
Figure 6. NP-11948
Figure 7. Radiprodil
Figure 8. Others
Figure 9. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application in 2021
Figure 10. Acute Ischemic Stroke
Figure 11. Autism
Figure 12. Brain Ischemia
Figure 13. Burns
Figure 14. Others
Figure 15. Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 16. Global Glutamate Receptor Ionotropic NMDA 2B Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Sales (2017-2028) & (K Pcs)
Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Price (2017-2028) & (USD/Pcs)
Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity (2017-2028) & (K Pcs)
Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Glutamate Receptor Ionotropic NMDA 2B Market Drivers
Figure 22. Glutamate Receptor Ionotropic NMDA 2B Market Restraints
Figure 23. Glutamate Receptor Ionotropic NMDA 2B Market Trends
Figure 24. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturer in 2021
Figure 25. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Manufacturer in 2021
Figure 26. Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Glutamate Receptor Ionotropic NMDA 2B Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Glutamate Receptor Ionotropic NMDA 2B Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2017-2028)
Figure 30. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2017-2028)
Figure 31. North America Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028) & (USD Million)
Figure 32. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028) & (USD Million)
Figure 34. South America Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue (2017-2028) & (USD Million)
Figure 36. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2028)
Figure 37. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2017-2028)
Figure 38. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2017-2028) & (USD/Pcs)
Figure 39. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2028)
Figure 40. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2017-2028)
Figure 41. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2017-2028) & (USD/Pcs)
Figure 42. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2028)
Figure 43. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2028)
Figure 44. North America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2017-2028)
Figure 45. North America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2017-2028)
Figure 46. United States Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2028)
Figure 50. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2028)
Figure 51. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2017-2028)
Figure 52. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2017-2028)
Figure 53. Germany Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2017-2028)
Figure 62. China Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2028)
Figure 69. South America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2028)
Figure 70. South America Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2017-2028)
Figure 71. South America Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Glutamate Receptor Ionotropic NMDA 2B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B in 2021
Figure 83. Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B
Figure 84. Glutamate Receptor Ionotropic NMDA 2B Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
